A federal court in Florida has dismissed all claims—without leave to amend—against all generic ranitidine and store-brand manufacturers in the multidistrict litigation over the heartburn medication Zantac and its generic ranitidine equivalents. Having earlier dismissed Plaintiffs’ initial claims with leave to replead a narrow subset, Judge Robin Rosenberg of the United States District Court for the Southern District of Florida has now dismissed all claims without leave to amend on the grounds of…
By: Goodell, DeVries, Leech & Dann, LLP
By: Goodell, DeVries, Leech & Dann, LLP
